Manipulation under anaesthesia combined with Platelet-Rich Plasma joint on the Efficacy in the treatment of scapulohumeral periarthritis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300075226

Enrollment

Unknown

Registered

2023-08-30

Start date

2023-09-01

Completion date

Unknown

Last updated

2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scapulohumeral periarthritis

Interventions

Treatment group (Release under general anesthesia combined with platelet rich plasma injection):None

Control group (Release under general anesthesia):None

Eligibility

Sex/Gender

All

Age

40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients in the freezing period of adhesive shoulder capsitis, aged 40-60 years old; Course of disease 3 months to 3 years; High compliance, understanding, agreeing to participate in the study and signing the informed notice.

Exclusion criteria

Exclusion criteria: Accompanied by rotator cuff tear, shoulder joint local fracture, osteoma and other diseases; Contraindications of platelet rich plasma injection or contraindications of release under general anesthesia; Pregnant or lactating women; Complicated with severe cardiovascular and cerebrovascular diseases; Patients with low compliance who did not follow my team's treatment plan.

Design outcomes

Primary

Measure	Time frame
VAS;	—

Secondary

Measure	Time frame
Constant-Murley;JOA ;	—

Countries

China

Contacts

Public ContactChou Tianwei

Shanghai Jing 'an District Shibei Hospital

sbyyttk@qq.com+86 156 1880 9339

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026